Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
Pharmacotherapy for Cannabis Dependence: How Close Are We
CNS Drugs, 06/29/09
Vandrey R et al. - Results from controlled laboratory studies and small open-label clinical studies indicate that buspirone, dronabinol, fluoxetine, lithium and lofexidine may have therapeutic benefit for those seeking treatment for cannabis-related problems. However, controlled clinical trials have not been conducted and are needed to both confirm the potential clinical efficacy of these medications and to validate the laboratory models being used to study candidate medications.
Related Articles
New UK study suggests minimal relationship between cannabis and schizophrenia or psychosis
EurekAlert, 10/23/09
Relevance Score: 91%
If cannabis caused schizophrenia how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations
Addiction, 10/19/09
Relevance Score: 91%
Adverse health effects of non-medical cannabis use
The Lancet, 10/19/09
Relevance Score: 88%
Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
Schizophrenia Bulletin, 11/16/09
Relevance Score: 87%
Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study
Journal of the American Academy of Child and Adolescent Psychiatry, 10/29/09
Relevance Score: 87%
Today in Mental Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Anorexia Nervosa
FOCUS (The Journal of Lifelong Learning in Psychiatry), 12/09/09
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Therapeutics and Clinical Risk Management, 12/09/09
The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis
International Journal of Obesity, 12/09/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Psychophysiological disorders among buprenorphine patients
International Journal of Psychiatry in Clinical Practice, 12/09/09
High-potency cannabis and the risk of psychosis
British Journal of Psychiatry, 12/09/09
A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence
Journal of Psychopharmacology, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


